Skip to content
Business Company News, Oil Mining Resources

Marmota Limited (ASX:MEU) Extends Titanium Discovery West with 100% Leucoxene Confirmation

Jane Morgan Management 2 mins read

24 February 2025 – Perth, Australia | Marmota Limited (ASX:MEU) (“Marmota” or the “Company”) is pleased to announce that 100% leucoxene, which is a high-value titanium mineral (TiO₂), has been identified in all observed Heavy Mineral (HM) concentrate samples from historical drill holes that are located immediately west of Marmota’s Muckanippie Titanium Heavy Mineral Sands Discovery site.

This discovery extends the potential strike length of the Muckanippie titanium discovery to 9 kilometers.

Highlights

  • Historical drill samples confirm high-grade titanium mineralisation on site:

    • 100% leucoxene observed in all HM concentrate samples.

    • Samples originate from two Flinders Mines Ltd (now Red Hawk Mining Ltd ASX:RHK) drill holes on tenement EL6679, which is now 100%-owned by Marmota.

  • Strategic Expansion of the Titanium Discovery:

    • The latest discovery now extends Marmota’s titanium-heavy mineral sands potential 9km lenght along strike.

    • This confirmed leucoxene-rich mineralisation further validates the palaeochannel’s potential.

  • Significant Historical Drill Results:

    • Hole FCGDH-019 (15–19m): 100% Leucoxene

    • Hole FCGDH-020 (27–30m): 100% Leucoxene

    • The distance between the two holes is 277m reinforcing the lateral extent of the mineralisation.

  • Leucoxene’s High-Value Applications:

    • A premium titanium dioxide (TiO₂) mineral, which is essential for industries like aerospace, medicine, creating pigments, and even battery industries. 

    • Recognised and classified globally as a “critical mineral”. 

Marmota’s Titanium Discovery Progression

  • January 2025: 

    • Bonanza-grade heavy mineral (HM) assays confirmed at Muckanippie (EL6166), featuring high TiO₂ grades over thick intervals from the surface​.

  • February 2025: 

    • Marmota expanded drilling westward following strong visual indications of heavy mineral sands​.

  • Now/Today: 

    • Historical data confirms 100% leucoxene to west, significantly increasing the scale of Marmota’s discovery​.

For Further Information:

Dr Colin Rose
Executive Chairman
Marmota Limited
[email protected]


About us:

About Marmota Limited

Marmota Limited (ASX: MEU) is a South Australian mining exploration company focused on gold, titanium, and uranium. Its gold exploration is centred on the Aurora Tank discovery, while its flagship uranium resource is at Junction Dam, adjacent to the Honeymoon mine.

For more information, visit www.marmota.com.au


Contact details:

Jane Morgan
Jane Morgan Management
Investor & Media Relations
[email protected]

Media

More from this category

  • Business Company News, Oil Mining Resources
  • 13/02/2026
  • 11:17
Jane Morgan Management

Austral Resources (ASX:AR1) advances Rocklands growth strategy with new drilling campaign and Metal Bank tolling MoU

13 February 2026 – Brisbane, Australia | Austral Resources Australia Ltd (ASX:AR1) has launched the next phase of its Rocklands growth strategy, announcing the…

  • Contains:
  • Oil Mining Resources
  • 12/02/2026
  • 16:10
Robex Resources Inc.

Robex Achieves Commercial Production at the Kiniero Gold Project

QUÉBEC CITY, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Robex Resources Inc. (“Robex” or the “Company”) is pleased to announce that it has achieved commercial production at its Kiniero Gold Project in Guinea, having satisfied the commercial production criteria under both its Senior Secured Facility Agreement with Sprott and the Guinea Mining Code.Commercial production status was achieved following the first shipment of gold on 11 February 2026. The shipment comprised approximately 197 kilograms of gold, equivalent to 6,336 troy ounces.Under the Guinea Mining Code, the date of first commercial production is defined as the earlier of either the completion of a…

  • Biotechnology, Business Company News
  • 12/02/2026
  • 12:22
Jane Morgan Management

BlinkLab Limited (ASX:BB1) Expands Pivotal FDA Trial Network to Nine Elite U.S. Sites Ahead of Imminent Study Commencement

12February 2026 – Sydney, Australia | BlinkLab Limited (ASX:BB1), a leader in AI-powered digital diagnostics, has expanded its U.S. clinical footprint with the onboarding…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.